Trial Information

Official Title: Does Ultrasound-Guidance Improve the Delivery and Efficacy of Intramuscular (IM) Injection of Sandostatin LAR in the Treatment of Acromegaly

Summary

The purpose of this study is to determine the difference in drug levels of Sandostatin after IM injection of Sandostatin LAR without ultrasound guidance (as is the standard of care) compared to drug levels of Sandostatin after IM injection of Sandostatin LAR with ultrasound guidance in subjects with Acromegaly.

Phase: N/A

Sponsor: Cedars-Sinai Medical Center

Overall Contacts:

Billy Gellepis
(310) 423-3395
gellepisw@cshs.org

Lori Korsakoff, RN, BSN
Phone: (310) 423-2411
korsakoffl@cshs.org